Rocephin - API Insight, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Rocephin - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Rocephin - API Insight, 2019 provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Rocephin. The report also highlights the patent details of Rocephin.

Scope of the Report

  • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
  • Patent information around Rocephin in United States (US) and Europe (EU) has been highlighted
  • API manufacturers for Rocephin in United States, Europe, China and India
  • The report contains historical and forecasted sales for Rocephin till 2021
  • Enlists the market competition and emerging therapies in the space where Rocephin operates

Reasons to Buy

  • Evaluate the marketing status of Rocephin to exploit opportunities for generic Rocephin development opportunities
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Rocephin
  • API intelligence over Rocephin and gaining primary intelligence over Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth analysis of the Rocephin's performance

Topics Covered

1. Rocephin Overview

2. Rocephin Global Sales Assessment

  • Rocephin Historical Global Sales
  • Rocephin Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/zs6mc8/rocephin_api?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related Topics: Central Nervous System Drugs , Infectious Diseases Drugs, Gastrointestinal Drugs , Antibiotics, Urological Disorders Drugs, Bronchitis Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related Topics: Central Nervous System Drugs , Infectious Diseases Drugs, Gastrointestinal Drugs , Antibiotics, Urological Disorders Drugs, Bronchitis Drugs